Understanding the Pete Hegseth Military Testosterone Policy: A Comprehensive Guide

Pete Hegseth Military Testosterone Policy: Full Guide for Service Members

The Pete Hegseth military testosterone policy mandates annual testosterone deficiency screening for all active-duty and reserve service members aged 30 and older, with voluntary testing for those under 30 . The Pentagon calls the program “High-T Department of War” and offers voluntary testosterone replacement therapy (TRT) to troops diagnosed with deficiency, aiming to optimize physical and mental readiness . The policy took effect immediately as of July 2026, with full implementation protocols due by August 15, 2026 .

Quick Facts

What Is the Hegseth Testosterone Screening Policy?

The Hegseth military testosterone policy is a Department of Defense directive requiring routine screening for testosterone deficiency among service members. Announced by Secretary of War Pete Hegseth on July 15, 2026, the program aims to identify and treat low testosterone levels to maintain force readiness .

What the Policy Does

The policy mandates that:

• All service members aged 30 and older undergo annual testosterone screening as part of their required Periodic Health Assessment 

• Service members under 30 may volunteer for testing 

• Service members diagnosed with deficiency are offered voluntary testosterone replacement therapy 

• The screening is a blood test conducted during routine medical exams 

Why It Matters

Secretary Hegseth framed the initiative as an investment in “the individual warfighter” and a “sacred duty” to maintain the military’s tactical advantage . He stated the program is “not about artificial enhancement,” but rather “restoring and optimizing your natural capabilities, protecting your longevity and ensuring you have the biological foundation required to sustain the fight” .

The policy also responds to the growing recognition that hormonal deficiencies may be underdiagnosed among service members—particularly those exposed to demanding training, irregular sleep, injuries, and prolonged stress .

What Troops Should Do Next

• Age 30+: Expect testosterone screening at your next annual Periodic Health Assessment

• Under 30: Ask your healthcare provider about voluntary testing if you have concerns

• On TRT or considering it: Discuss fertility implications with your provider before starting treatment

• For all troops: Keep records of all hormone-related testing and treatments—this documentation may be relevant for future VA disability claims if you experience service-connected hormonal conditions

Who Qualifies for Testing and Treatment

Testing Eligibility

Treatment Eligibility

If screening reveals testosterone deficiency, service members are offered testosterone replacement therapy. Treatment is voluntary—troops may decline .

Who Qualifies for Disability Benefits Related to Hormonal Conditions

If you develop a service-connected hormonal condition, you may qualify for VA disability compensation. Conditions that may be service-connected include:

• Hypogonadism (low testosterone)

• Infertility related to hormone treatment

• Secondary conditions such as depression, fatigue, or osteoporosis

What veterans should do:

1. Document all hormone testing and treatment received during service

2. File VA Form 21-526EZ for disability compensation

3. Include a nexus letter from a qualified medical provider linking your condition to military service

4. Schedule a C&P exam to evaluate your condition

How the Screening Process Works

Step 1: Annual Periodic Health Assessment

Service members aged 30 and older will undergo testosterone screening as part of their required annual medical exam . The test is a simple blood draw.

Step 2: Test Interpretation

Testosterone levels naturally fluctuate based on:

• Time of day (levels are highest in the morning) 

• Recent food intake

• Exercise

• Illness or injury

• Sleep quality 

Under medical guidelines, a single low reading is not sufficient for diagnosis. Physicians typically require:

• At least two early-morning, fasting readings 

• Documented symptoms consistent with testosterone deficiency 

• Evaluation of potentially reversible causes (obesity, medication side effects, sleep disorders) 

Step 3: Treatment Decision

If deficiency is confirmed, troops are offered voluntary testosterone replacement therapy. Treatment can be administered through:

• Injections

• Gels

• Patches

• Other formulations 

Important: TRT can significantly reduce sperm production. The Endocrine Society recommends against prescribing testosterone to men planning to father children in the near term .

Step 4: Ongoing Monitoring

Patients on testosterone therapy require regular clinical monitoring to ensure they are not receiving excessive hormone doses. Testosterone can increase red blood cell production, requiring additional monitoring .

Common Questions

Are service members required to get testosterone replacement therapy?

No. Testosterone replacement therapy is entirely voluntary. Hegseth explicitly stated that if medical teams recommend treatment, “it would be that individual’s decision whether to receive testosterone replacement therapy” <span class=””>.

Does the policy apply to female service members?

The Pentagon has not clearly stated whether the policy applies to women or what diagnostic standards will be used . The announcement appears to focus on male troops. Critics—including Senator Tammy Duckworth (D-IL) and Representative Chrissy Houlahan (D-PA)—have called for hormone screening to be made available for both men and women .

What is the connection to the transgender troop ban?

A federal judge is examining whether the testosterone policy conflicts with the Trump administration’s transgender military ban. U.S. District Judge Ana Reyes noted that the ban says troops must serve “without the benefit of routine medical treatment”—and she has ordered both parties to address similarities and differences between providing TRT to transgender men versus other service members <span class=””>.

What are the known risks of testosterone replacement therapy?

Known risks include:

• Reduced sperm production and infertility 

• Possible increased cardiovascular risk 

• Dependency—the body can stop producing testosterone naturally, creating a long-term medical need 

• Need for ongoing monitoring to prevent excessive dosing 

Can testosterone therapy affect fertility?

Yes. The Endocrine Society recommends against prescribing testosterone therapy to men planning to have children in the near term . Dr. Mohit Khera, who led an FDA expert panel on testosterone, warned that “if young men do take testosterone, it can make them infertile” .

Does TRICARE cover infertility treatment if I become infertile from TRT?

Generally, TRICARE does not cover assisted reproductive technologies such as in vitro fertilization, intrauterine insemination, or cryopreservation . Congress nearly expanded coverage in the FY2026 defense authorization bill, but the provision did not survive final negotiations .

What did the VA Inspector General find about testosterone treatment at the VA?

A 2018 VA Office of Inspector General review found that VA providers often started patients on testosterone without:

• Adequately documenting symptoms

• Confirming low levels with multiple tests

• Conducting recommended follow-up monitoring

Approximately 2 out of 3 patients did not receive documented discussion of treatment risks and benefits before starting .

What happens to my TRT if I leave the military?

If you begin testosterone therapy on active duty and later separate, your care may transfer to the Department of Veterans Affairs. However, the VA has not stated how it will handle these transitions . Medical experts warn that patients cannot simply stop testosterone abruptly—the body can become dependent, and stopping can cause significant side effects .

Is there scientific evidence supporting routine testosterone screening?

Medical guidelines generally recommend against blanket screening of asymptomatic individuals. The Endocrine Society—which represents physicians specializing in hormonal health—stated there is “insufficient evidence to support a general recommendation to perform population-level screening for hypogonadism in asymptomatic men” . Current guidelines recommend testing only for men who have symptoms and documented low levels on at least two separate blood tests .

Does testosterone decline naturally in all men?

Yes. Testosterone levels in men decline by roughly 1 percent per year after age 30 or 40 . However, not all men with levels below a statistical threshold experience symptoms or require treatment.

How many troops will be affected by this policy?

More than 451,000 active-duty service members were age 31 or older in 2024—a conservative figure that excludes 30-year-olds and reserve components . Approximately 82 percent of active-duty service members are men .

Are there any changes to the FDA’s testosterone prescribing rules?

Yes. In June 2026, the FDA proposed loosening prescribing limits on testosterone gels, pills, patches, and injections . The FDA previously removed a boxed warning about heart attack and stroke risks in 2025. Health Secretary Robert F. Kennedy Jr. has also advocated for wider access to testosterone therapy .

Key Takeaways

• Secretary Hegseth announced mandatory annual testosterone screening for service members age 30+ on July 15, 2026; testing is voluntary for those under 30 

• Screening is a blood test added to the Periodic Health Assessment; treatment is voluntary 

• The Endocrine Society—the leading medical authority on hormonal health—opposes blanket screening of asymptomatic individuals 

• Testosterone therapy can cause infertility and create long-term dependency, requiring ongoing medical care 

• The VA has historically struggled to manage testosterone therapy appropriately, with a 2018 Inspector General report finding widespread documentation failures 

• TRICARE generally does not cover infertility treatment, even though TRT can cause infertility 

• A federal judge is examining whether the policy conflicts with the transgender troop ban 

• Full implementation protocols are due by August 15, 2026 

• Female troops—and the potential for estrogen-related screening—have not been addressed by the Pentagon 

• Veterans who develop service-connected hormonal conditions may qualify for VA disability compensation; document all treatment received during service

Official Resources